Pathways linked to immunometabolism were of particular interest, including type 1 and type 2 diabetes mellitus signaling, PPARα/RXRα activation, cyclic AMP (cAMP)-mediated signaling, and HIF1α signaling. Here, RXRA is linked to diabetes mellitus.